Differential regulation of RasGAPs in cancer

Genes and Cancer

Volumn 2, Issue 3, 2011, Pages 288-297

  Grewal, Thomas ^a   Koeses, Meryem ^a   Tebar, Francesc ^b   Enrich, Carlos ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

GAP1; NF1; P120GAP; Ras GAP assembly; Scaffolds

Indexed keywords

CALCIUM ION PROMOTED RAS INACTIVATOR PROTEIN; CALMODULIN BINDING PROTEIN; CYTOPLASMIC PHOSPHOLIPASE A2; GROWTH FACTOR RECEPTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1IP4BP; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1M; ISOENZYME; NEUROFIBROMIN; PLECKSTRIN; PROTEIN ANXA6; PROTEIN KINASE C; PROTEIN RASAL; PROTEIN SH2; PROTEIN SH3; RAS PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

CANCER GROWTH; CARCINOGENESIS; CELL TRANSFORMATION; COLON CANCER; DOWN REGULATION; ENDOSOME; ENZYME ACTIVITY; EPIGENETICS; GENE FUNCTION; GENE INACTIVATION; GENE SILENCING; GENETIC DIFFERENCE; HUMAN; MATRIX ATTACHMENT REGION; METHYLATION; NEOPLASM; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 79960096960     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911407330     Document Type: Review

References (135)

1. Barbacid M. Ras genes. Ann Rev Biochem. 1987;56:799-827.
2. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682-9.
3. Downward J. Targeting ras signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11-22.
4. Grewal T, Tebar F, Pol A, Enrich C. Involvement of targeting and scaffolding proteins in the regulation of the EGFR/Ras/MAPK pathway in oncogenesis. Curr Signal Trans Ther. 2006;1:147-67.
5. Buday L, Downward J. Many faces of Ras activation. Biochim Biophys Acta. 2008;1786:178-87.
6. Wellbrock C, Karasarides M, Marais R. The Raf proteins take centre stage. Nat Rev Mol Cell Biol. 2004;5:875-85.
7. Vetter IR, Wittinghofer A. The guaninenucleotide- binding switch in three dimensions. Science. 2001;294:1299-304.
8. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell. 2007;129:865-77.
9. Scheffzek K, Ahmadian MR, Kabsch W, et al. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science. 1997;277:333-8.
10. Ahmadian MR, Hoffmann U, Goody RS, Wittinghofer A. Individual rate constants for the interaction of Ras proteins with GTPaseactivating proteins determined by fluorescence spectroscopy. Biochemistry. 1997;36:4535-41.
11. Ahmadian MR, Kiel C, Stege P, Scheffzek K. Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP. J Mol Biol. 2003;329:699-710.
12. Kupzig S, Deaconescu D, Bouyoucef D, et al. GAP1 family members constitute bifunctional Ras and Rap GTPase-activating proteins. J Biol Chem. 2006;281:9891-900.
13. Kupzig S, Bouyoucef-Cherchalli D, Yarwood S, Sessions R, Cullen PJ. The ability of GAP1IP4BP to function as a Rap1 GTPase-activating protein (GAP) requires its Ras GAP-related domain and an arginine finger rather than an asparagine thumb. Mol Cell Biol. 2009;29:3929-40.
14. Yarwood S, Bouyoucef-Cherchalli D, Cullen PJ, Kupzig S. The GAP1 family of GTPaseactivating proteins: spatial and temporal regulators of small GTPase signalling. Biochem Soc Trans. 2006;34:846-50.
15. Sot B, Koetting C, Deaconescu D, Suveyzdis Y, Gerwert K, Wittinghofer A. Unravelling the mechanism of dual-specificity GAPs. EMBO J. 2010;29:1205-14.
16. Koera K, Nakamura K, Nakao K, et al. K-ras is essential for the development of the mouse embryo. Oncogene. 1997;15:1151-9.
17. Esteban LM, Vicario-Abejon C, Fernandez- Salguero P, et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol. 2001;21:1444-52.
18. Plowman SJ, Williamson DJ, O'Sullivan MJ, et al. While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol Cell Biol. 2003;23: 9245-50.
19. Omerovic J, Laude AJ, Prior IA. Ras proteins: paradigms for compartmentalised and isoformspecific signalling. Cell Mol Life Sci. 2007; 64:2575-89.
20. Schubbert S, Zenker M, Rowe SL, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38:331-6.
21. Kratz CP, Niemeyer CM, Zenker M. An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med. 2007;85:223-31.
22. Yan J, Roy S, Apolloni A, Lane A, Hancock JF. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem. 1998;273:24052-6.
23. Walsh AB, Bar-Sagi D. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J Biol Chem. 2001;76:15609-15.
24. Cullen PJ, Lockyer PJ. Integration of calcium and ras signalling. Nat Rev Mol Cell Biol. 2002;3:339-48.
25. Donovan S, Shannon KM, Bollag G. GTPase activating proteins: critical regulators of intracellular signaling. Biochim Biophys Acta. 2001;87510:1-23.
26. Bernards A, Settleman J. GAPs in growth factor signalling. Growth Factors. 2005;23:143-9.
27. Le LQ, Parada LF. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene. 2007;26:4609-16.
28. Dasgupta B, Gutmann DH. Neurofibromatosis 1: closing the GAP between mice and men. Curr Opin Gen Dev. 2003;13:20-7.
29. Pamonsinlapatham P, Hadj-Slimane R, Lepelletier Y, et al. P120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling. Biochimie. 2009;91: 320-8.
30. Grewal T, Enrich C. Molecular mechanisms involved in Ras inactivation: the annexin A6-p120GAP complex. Bioessays. 2008;28: 1211-20.
31. Westbrook TF, Martin ES, Schlabach MR, et al. A genetic screen for candidate tumor suppressors identifies REST. Cell. 2005;121:837-48.
32. Jin H, Wang X, Ying Y, et al. Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci U S A. 2007;104:12353-8.
33. Calvisi DF, Ladu S, Conner EA, et al. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol. 2011;54:311-9.
34. Ohta M, Seto M, Ijichi H, et al. Decreased expression of the Ras-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Gastroenterology. 2009;136: 206-16.
35. Kolfschoten IG, van Leeuwen B, Berns K, et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell. 2005;121:849-58.
36. Qiu GH, Xie H, Wheelhouse N, et al. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. J Hepatol. 2007;46:655-63.
37. Boon LM, Mulliken JB, Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev. 2005;15:265-9.
38. Grewal T, Evans R, Rentero C, et al. Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity. Oncogene. 2005;24:5809-20.
39. de Muga SV, Timpson P, Cubells L, et al. Annexin A6 inhibits Ras signalling in EGF receptor overexpressing breast cancer cells. Oncogene. 2009;28:363-77.
40. Enrich C, Rentero C, de Muga SV, et al. Annexin A6-linking Ca(2+) signaling with cholesterol transport. Biochim Biophys Acta. Epub 2010 Oct 1.
41. Henis YI, Hancock JF, Prior IA. Ras acylation, compartmentalization and signaling nanoclusters. Mol Membr Biol. 2009;26:80-92.
42. Calvo F, Agudo-Ibáñez L, Crespo P. The Ras- Erk pathway: understanding site-specific signaling provides hope of new anti-tumor therapies. Bioessays. 2010;32:412-21.
43. Fehrenbacher N, Bar-Sagi D, Philips M. Ras/ MAPK signaling from endomembranes. Mol Oncol. 2009;3:297-307.
44. Choy E, Chiu VK, Silletti J, et al. Endomembrane trafficking of Ras: the CAAX motif targets proteins to the ER and Golgi. Cell. 1999;98: 69-80.
45. Roy S, Wyse B, Hancock JF. H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis. Mol Cell Biol. 2002;22:5128-40.
46. Gomez GA, Daniotti JL. H-Ras dynamically interacts with recycling endosomes in CHO-K1 cells: involvement of Rab5 and Rab11 in the trafficking of H-Ras to this pericentriolar endocytic compartment. J Biol Chem. 2005;280:34997-5010.
47. Lu A, Tebar F, Alvarez-Moya B, et al. A clathrindependent pathway leads to KRas signaling on late endosomes en route to lysosomes. J Cell Biol. 2009;184:863-79.
48. Rebollo A, Perez-Sala D, Martinez AC. Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis. Oncogene. 1999;18:4930-9.
49. Wolfman JC, Wolfman A. Endogenous c-N-Ras provides a steady-state anti-apoptotic signal. J Biol Chem. 2000;275:19315-23.
50. Matallanas D, Arozarena I, Berciano MT, et al. Differences in the inhibitory specificities of H-Ras, K-Ras and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem. 2003;278: 4572-81.
51. Caloca MJ, Zugaza JL, Bustelo XR. Exchange factors of the RasGRP family mediate Ras activation in the Golgi. J Biol Chem. 2003;278: 33465-73.
52. Bivona TG, Perez De Castro I, Ahearn IM, et al. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature. 2003;424:694-8.
53. Arozarena I, Matallanas D, Berciano MT, et al. Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors. Mol Cell Biol. 2004;24:1516-30.
54. Murakoshi H, Iino R, Kobayashi T, et al. Single molecule imaging analysis of Ras activation in living cells. Proc Natl Acad Sci U S A. 2004;101:7317-22.
55. Kolch W, Calder M, Gilbert D. When kinases meet mathematics: the systems biology of MAPK signalling. FEBS Lett. 2005;579:1891-5.
56. Raabe T, Rapp UR. Ras signaling: PP2A puts Ksr and Raf in the right place. Curr Biol. 2003;13:R635-7.
57. Li C, Cheng Y, Gutmann DA, Mangoura D. Differential localization of neurofibromatosis (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Dev Brain Res. 2001;130:231-48.
58. Roudebush M, Slabe T, Sundaram V, Hoppel CL, Golubic M, Stacey DW. Neurofibromin colocalizes with mitochondria in cultured cells. Exp Cell Res. 1997;236:161-72.
59. Nordlund M, Gu X, Shipley MT, Ratner N. Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons. J Neurosci. 1993;13:1588-600.
60. Wang Z, Tung PS, Moran MF. Association of p120 ras GAP with endocytic components and colocalization with epidermal growth factor (EGF) receptor in response to EGF stimulation. Cell Growth Differ. 1996;7:123-33.
61. Boyanapalli M, Lahoud OB, Mesian L, et al. Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. Biochem Biophys Res Commun. 2006;340:1200-8.
62. Delint-Ramirez I, Fernández E, Bayés A, Kicsi E, Komiyama NH, Grant SG. In vivo composition of NMDA receptor signaling complexes differs between membrane subdomains and is modulated by PSD-95 and PSD-93. J Neurosci. 2010;30:8162-70.
63. Huang JW, Chen CL, Chuang NN. P120-GAP associated with syndecan-2 to function as an active switch signal for Src upon transformation with oncogenic ras. Biochem Biophys Res Commun. 2005;329:855-62.
64. Koehler JA, Moran MF. Regulation of extracellular signal-regulated kinase activity by p120 Ras- GAP does not involve its pleckstrin homology or calcium-dependent lipid binding domains but does require these domains to regulate cell proliferation. Cell Growth Differ. 2001;12:551-61.
65. Koehler JA, Moran MF. RACK1, a protein kinase C scaffolding protein, interacts with the PH domain of p120GAP. Biochem Biophys Res Commun. 2001;283:888-95.
66. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7:295-308.
67. Vandenbroucke I, Van Oostveldt P, Coene E, De Paepe A, Messiaen L. Neurofibromin is actively transported to the nucleus. FEBS Lett. 2004;560:98-102.
68. D'Angelo I, Welti S, Bonneau F, Scheffzek K. A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep. 2006;7:174-9.
69. Mousley CJ, Tyeryar KR, Ryan MM, Bankaitis VA. Sec14p-like proteins regulate phosphoinositide homeostasis and intracellular protein and lipid trafficking in yeast. Biochem Soc Trans.2006;34:346-50.
70. Welti S, Fraterman S, D'Angelo I, Wilm M, Scheffzek K. The Sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectroscopy and structure of a lipid complex. J Mol Med. 2007;366:551-62.
71. Izawa I, Tamaki N, Saya H. Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett. 1996;382:53-9.
72. Feng L, Yunoue S, Tokuo H, et al. PKA phosphorylation and 14-3-3 interaction regulate the function of the neurofibromatosis type 1 tumor suppressor neurofibromin. FEBS Lett. 2004;557:275-82.
73. Mangoura D, Sun Y, Li C, et al. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene. 2006;25:735-45.
74. Leondaritis G, Petrikkos L, Mangoura D. Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C/Ras/extracellular signalregulated kinase 1/2 pathway signaling and neuronal differentiation. J Neurochem. 2009;109:573-83.
75. Plowman SJ, Muncke C, Parton RG, Hancock JF. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc Natl Acad Sci U S A. 2005;102:15500-5.
76. Cichowski K, Santiago S, Jardim M, Johnson BW, Jacks T. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev. 2003;17:449-54.
77. Phan VT, Ding VW, Li F, Chalkley RJ, Burlingame A, McCormick F. The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans. Mol Cell Biol. 2010;30:2264-79.
78. Kaufmann D, Junge I, Bartelt B, Lattke H, Müller R. On the lysosomal degradation of neurofibromin and its phosphorylation in cultured melanocytes. Biol Chem. 1999;380:1071-8.
79. Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev. 2008;88:1341-78.
80. Kheifets V, Mochly-Rosen D. Insight into intraand inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res. 2007;55:467-76.
81. Kirschner LS, Yin Z, Jones GN, Mahoney E. Mouse models of altered protein kinase A signaling. Endocr Relat Cancer. 2009;16:773-93.
82. Taylor SS, Kim C, Cheng CY, Brown SH, Wu J, Kannan N. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochim Biophys Acta. 2008;1784:16-26.
83. Mulay V, Wood P, Rentero C, Enrich C, Grewal T. Signal transduction pathways provide opportunities to enhance HDL and apoAI-dependent reverse cholesterol transport. Curr Pharm Biotech. In press.
84. Cooper JA, Kashishian A. In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase. Mol Cell Biol. 1993;3:1737-45.
85. Kazlauskas A, Ellis C, Pawson T, Cooper JA. Binding of GAP to activated PDGF receptors. Science. 1990;247:1578-81.
86. Jones RB, Gordus A, Krall JA, MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006;439:168-74.
87. Moran MF, Polakis P, McCormick F, Pawson T, Ellis C. Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPaseactivating protein. Mol Cell Biol. 1991;11:1804-12.
88. Ellis C, Measday V, Moran MF. Phosphorylation- dependent complexes of p120 Ras-specific GTPase-activating protein with p62 and p190. Methods Enzymol. 1995;255:179-92.
89. Zhao M, Janas JA, Niki M, Pandolfi PP, Van Aelst L. Dok-1 independently attenuates Ras/mitogenactivated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis. Mol Cell Biol. 2006;26:2479-89.
90. Carpino N, Wisniewski D, Strife A, et al. p62(dok): a constitutively tyrosine-phosphorylated, GAPassociated protein in chronic myelogenous leukemia progenitor cells. Cell. 1997;88:197-204.
91. Yamanashi Y, Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell. 1997;88:205-11.
92. van der Geer P, Henkemeyer M, Jacks T, Pawson T. 1997. Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap. Mol Cell Biol. 1997;17:1840-7.
93. Kulkarni SV, Gish G, van der Geer P, Henkemeyer M, Pawson T. Role of p120 Ras-GAP in directed cell movement. J Cell Biol. 2000;149:457-70.
94. Endo M, Yamashita T. Inactivation of Ras by p120GAP via focal adhesion kinase dephosphorylation mediates RGMa-induced growth cone collapse. J Neurosci. 2009;29:6649-62.
95. Pamonsinlapatham P, Gril B, Dufour S, et al. Capns1, a new binding partner of RasGAP-SH3 domain in K-Ras(V12) oncogenic cells: modulation of cell survival and migration. Cell Signal. 2008;20:2119-26.
96. Leblanc V, Tocque B, Delumeau I. Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain. Mol Cell Biol. 1998;18:5567-78.
97. Lemmon MA. Pleckstrin homology domains: two halves make a hole? Cell. 2005;120:574-6.
98. Drugan JK, Rogers-Graham K, Gilmer T, Campbell S, Clark GJ. The Ras/p120 GTPase-activating protein (GAP) interaction is regulated by the p120 GAP pleckstrin homology domain. J Biol Chem.2000;275:35021-7.
99. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. Stimulation of p21ras upon T-cell activation. Nature. 1990;346:719-23.
100. Mineo C, Ying YS, Chapline C, Jaken S, Anderson RG. Targeting of protein kinase Calpha to caveolae. J Cell Biol. 1998;141:601-10.
101. Davis AJ, Butt JT, Walker JH, Moss SE, Gawler DJ. The Ca2+-dependent lipid binding domain of p120GAP mediates protein-protein interactions with Ca2+-dependent membrane-binding proteins: evidence for a direct interaction between annexin 6 and p120GAP. J Biol Chem. 1996;271:24333-6.
102. Grewal T, Enrich C. Annexins: modulators of EGF receptor signalling and trafficking. Cell Signal. 2009;21:847-58.
103. Theobald J, Hanby A, Patel K, Moss SE. Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells. Br J Cancer. 1995;71:786-8.
104. Sermon BA, Eccleston JF, Skinner RH, Lowe PN. Mechanism of inhibition by arachidonic acid of the catalytic activity of Ras GTPase-activating proteins. J Biol Chem. 1996;271:1566-72.
105. Han JW, McCormick F, Macara IG. Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids. Science. 1991;252:576-9.
106. Cubells L, de Muga SV, Tebar F, et al. Annexin A6-induced inhibition of cytoplasmic phospholipase A2 is linked to caveolin-1 export from the Golgi. J Biol Chem. 2008;283:10174-83.
107. Rentero C, Evans R, Wood P, et al. Inhibition of H-Ras and MAPK is compensated by PKCdependent pathways in annexin A6 expressing cells. Cell Signal. 2006;18:1006-16.
108. Villalonga P, López-Alcalá C, Chiloeches A, et al. Calmodulin prevents activation of Ras by PKC in 3T3 fibroblasts. J Biol Chem. 2002;277: 37929-35.
109. Alvarez-Moya B, López-Alcalá C, Drosten M, Bachs O, Agell N. K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function. Oncogene. 2010;29:5911-22.
110. Cubells L, de Muga SV, Tebar F, et al. Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex. Traffic. 2007;8:1568-89.
111. Monastyrskaya K, Babiychuk EB, Hostettler A, Wood P, Grewal T, Draeger A. Plasma membrane-associated annexin A6 reduces Ca2+ entry by stabilizing the cortical actin cytoskeleton. J Biol Chem. 2009;284:17227-42.
112. Grewal T, Koese M, Rentero C, Enrich C. Annexin A6-regulator of the EGFR/Ras signalling pathway and cholesterol homeostasis. Int J Biochem Cell Biol. 2010;42:580-4.
113. Cozier GE, Lockyer PJ, Reynolds JS, et al. GAP1IP4BP contains a novel group I pleckstrin homology domain that directs constitutive plasma membrane association. J Biol Chem.2000;275:28261-8.
114. Lockyer PJ, Bottomley JR, Reynolds JS, et al. Distinct subcellular localisations of the putative inositol 1,3,4,5-tetrakisphosphate receptors GAP1IP4BP and GAP1m result from the GAP1IP4BP PH domain directing plasma membrane targeting. Curr Biol. 1997;7:1007-10.
115. Lockyer PJ, Wennstroem S, Kupzig S, et al. Identification of the ras GTPase-activating protein GAP1(m) as a phosphatidylinositol-3,4,5- trisphosphate-binding protein in vivo. Curr Biol. 999;9:265-8.
116. Cozier GE, Bouyoucef D, Cullen PJ. Engineering the phosphoinositide-binding profile of a class I pleckstrin homology domain. J Biol Chem. 2003;278:39489-96.
117. Nafisi H, Banihashemi B, Daigle M, Albert PR. GAP1(IP4BP)/RASA3 mediates Galphaiinduced inhibition of mitogen-activated protein kinase. J Biol Chem. 2008;283:35908-17.
118. Krapivinsky G, Medina I, Krapivinsky L, Gapon S, Clapham DE. SynGAP-MUPP1- CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron. 004;43:563-74.
119. Cook SJ, Lockyer PJ. Recent advances in Ca(2+)-dependent Ras regulation and cell proliferation. Cell Calcium. 2006;39:101-12.
120. Cullen PJ. Decoding complex Ca2+ signals through the modulation of Ras signaling. Curr Opin Cell Biol. 2006;18:157-61.
121. Lockyer PJ, Kupzig S, Cullen PJ. CAPRI regulates Ca(2+)-dependent inactivation of the Ras- MAPK pathway. Curr Biol. 2001;11:981-6.
122. Walker SA, Kupzig S, Bouyoucef D, Davies LC, Tsuboi T. Identification of a Ras GTPaseactivating protein regulated by receptor-mediated Ca2+-oscillations. EMBO J. 2004;23:1749-60.
123. Lio Q, Walker SA, Gao DC, et al. CAPRI and RASAL impose different modes of information processing on Ras due to contrasting temporal filtering of Ca2+. J Cell Biol. 2005;170: 183-90.
124. Zhang J, Guo J, Dzhagalov I, He Y-W. An essential function for the Ca2+-promoted Ras activator in Fc?-receptor-mediated phagocytosis. Nat Immunol. 2005;6:911-9.
125. Briggs MW, Sacks DB. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep. 2003;4:571-4.
126. Allen M, Chu S, Brill S, et al. Restricted tissue expression pattern of a novel human rasGAPrelated gene and its murine ortholog. Gene. 998;218:17-25.
127. Gao W, Kondo Y, Shen L, et al. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis. 2008;29:1901-10.
128. Chen H, Tooka S, Gazdar AF, Hsieh JT. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem. 2003;278:3121-30.
129. Dote H, Tooka S, Tsukuda K, et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin Cancer Res. 2004;10:2082-99.
130. Yano M, Toyooka S, Tsukuda K, et al. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int J Cancer. 2005;113:59-66.
131. Dote H, Tooka S, Tsukuda K, et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br J Cancer. 2005;92:1117-25.
132. Chen H, Tu SW, Hsieh JT. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem. 2005;280:22437-44.
133. Duggan D, Zheng SL, Knowlton M, et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst. 2007;46:655-63.
134. Smythe E, Smith PD, Jacob SM, Theobald J, Moss SE. Endocytosis occurs independently of annexin VI in human A431 cells. J Cell Biol. 994;124:301-6.
135. Boultwood J, Fidler C, Strickson AJ, et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood. 002;99:4638-41.